Stephens Consulting, LLC Anixa Biosciences Inc Transaction History
Stephens Consulting, LLC
- $422 Billion
- Q2 2025
A detailed history of Stephens Consulting, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 1,000 shares of ANIX stock, worth $3,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$3,020
Previous $2.86 Million
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
64Shares Held
5.37MCall Options Held
24.5KPut Options Held
23.4K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.21 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.88 Million0.29% of portfolio
-
D.A. Davidson & Co.614KShares$1.86 Million0.01% of portfolio
-
Ubs Group Ag524KShares$1.58 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.12 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $92.6M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...